Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins

Martin Hennenberg1, Jonel Trebicka, Erwin Biecker

  • 1Department of Internal Medicine I, University of Bonn, Bonn, Germany. Martin.Hennenberg@ukb.uni-bonn.de

Abstract

Insights

In cirrhosis, blood vessels become less responsive to angiotensin II due to desensitization of AT1-Rs by GRK-2 and beta-arrestin-2. This leads to decreased Ca2+ sensitivity and vasodilation, contributing to portal hypertension.

Area of Science:

  • Cardiovascular Biology
  • Hepatology
  • Molecular Pharmacology

Background:

  • Cirrhosis causes vascular hypocontractility, leading to vasodilation and portal hypertension.
  • Impaired contractile pathway activation contributes to this vascular dysfunction.
  • Angiotensin II type 1 receptors (AT1-Rs) are key in vascular contraction but can be desensitized.

Purpose of the Study:

  • To investigate the mechanisms of vascular hypocontractility to angiotensin II in cirrhosis.
  • To analyze the role of AT1-R signaling, G-proteins, GRKs, and beta-arrestin-2 in cirrhosis-associated vasodilation.

Main Methods:

  • Used bile duct ligation (BDL) to induce cirrhosis in rats and analyzed human hepatic arteries.
  • Measured vascular contractility using myography and assessed protein expression/phosphorylation via Western blot and immunoprecipitation.
  • Evaluated myosin light chain (MLC) phosphatase activity and phosphorylation of Ca(2+)-sensitizing proteins.

Main Results:

  • Aortas from BDL rats showed hyporeactivity to angiotensin II and reduced Ca2+ sensitivity.
  • GRK-2 and beta-arrestin-2 were upregulated, with increased beta-arrestin-2 binding to AT1-R in cirrhotic vessels.
  • Decreased phosphorylation of moesin and altered patterns of phosphorylated Ca(2+)-sensitizing proteins (MYPT1, CPI-17) were observed.

Conclusions:

  • Cirrhosis-induced vascular hypocontractility to angiotensin II is not due to altered AT1-R or G-protein expression.
  • AT1-R desensitization by GRK-2 and beta-arrestin-2, along with reduced Ca2+ sensitivity, contributes to vasodilation in cirrhosis.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...